Scientech Research’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,377
Closed -$55.7K – 437
2026
Q1
$55.7K Buy
+12,377
New +$64.5K 0.05% 403

Other funds holding MYGN

Scientech Research's MYGN Position: Q2 2026 in Review

Scientech Research sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 12,377 shares — an estimated $55.7K sold.

Scientech Research first reported a position in MYGN in Q1 2026 and held it in 1 quarter. The position peaked at $55.7K in Q1 2026. 199 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Scientech Research reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research sold 12,377 Myriad Genetics shares in Q2 2026, an estimated $55.7K.
  • Scientech Research first reported a position in Myriad Genetics in Q1 2026 and held it in 1 quarter.
  • Scientech Research's Myriad Genetics position peaked at $55.7K in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.